Discovery in T-cell research could lead to improved treatment of solid tumors

A local study led by the Agency for Science, Technology and Research (A*STAR) discovered that by inhibiting the function of two proteins, G9a and GLP, during the cell therapy production process, immune cells could become more effective in combatting cancer. These findings, published in the journal Nature Communications, can help advance the development of innovative therapies that could benefit cancer patients, bringing us closer to more effective targeted treatments for solid tumor cancers.